May 16 (Reuters) - Instil Bio Inc TIL.O :
* INSTIL BIO REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES CORPORATE UPDATE
* INSTIL BIO INC - EXPECTS CASH, CASH EQUIVALENTS,
MARKETABLE
SECURITIES AS OF MARCH 31, 2022, WILL ENABLE IT TO FUND ITS
OPERATING PLAN INTO 2024
* INSTIL BIO INC - QTRLY NET LOSS PER SHARE -GAAP $0.42
* INSTIL BIO INC - QTRLY NET LOSS PER SHARE - NON-GAAP $0.36
Source text for Eikon: ID:nGNXbGf4m3
Further company coverage: TIL.O
((Reuters.Briefs@thomsonreuters.com;))